Language: BG BG
nav.cta
← Back to results
Active (not recruiting) Phase 1 2025-521462-96-00

A Phase 1b, Open-Label Study of CLN-978 for the Treatment of Active, Moderate to Severe Sjogren’s Disease

Phase 1 – testing safety in a small group of people
Conditions: Sjogren's Disease

Sponsor: Cullinan Therapeutics Inc.

trial.available_in: БГ
Overview
Trial status: Authorised
Who can participate
Age group: 18-64 years, 65+ years Gender: Female, Male Target enrollment: 40 participants
Locations 4
France (1)
Germany (1)
Italy (1)
Poland (1)
Technical details
Status
Active (not recruiting)
Phase
Phase 1
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
04.07.2025
Registry ID
2025-521462-96-00
Source
euclinicaltrials.eu
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.